CD34+/M-cadherin+ bone marrow progenitor cells promote arteriogenesis in ischemic hindlimbs of ApoE-/- mice

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Terry, Toya ^a   Chen, Zhiqiang ^b   Dixon, Richard A F ^a   Vanderslice, Peter ^a   Zoldhelyi, Pierre ^a   Willerson, James T ^a,b   Liu, Qi ^a  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BASIC FIBROBLAST GROWTH FACTOR; CADHERIN; CD34 ANTIGEN; CYTOKINE; EPIDERMAL GROWTH FACTOR; FLT3 LIGAND; GREEN FLUORESCENT PROTEIN; M CADHERIN; PROTEIN CRG 2; SOMATOMEDIN C; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 3; M-CADHERIN; SIGNAL PEPTIDE;

ADULT STEM CELL; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; ATHEROSCLEROSIS; CELL DIFFERENTIATION; CELL HYPOXIA; COLONY FORMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; ENGRAFTMENT; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HINDLIMB; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LEG BLOOD FLOW; LEG ISCHEMIA; MORPHOMETRICS; MOUSE; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PROTEIN ANALYSIS; ANIMAL; BIOLOGICAL THERAPY; BLOOD FLOW; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CELL SEPARATION; CHEMISTRY; CYTOLOGY; GENETICS; HUMAN; ISCHEMIA; METABOLISM; METHODOLOGY; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHYSIOLOGY; STEM CELL; VASCULARIZATION;

MUS;

ANIMALS; ANTIGENS, CD34; APOLIPOPROTEINS E; BONE MARROW CELLS; CADHERINS; CELL SEPARATION; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINES; FLOW CYTOMETRY; HINDLIMB; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISCHEMIA; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEOVASCULARIZATION, PHYSIOLOGIC; PERIPHERAL ARTERIAL DISEASE; REGIONAL BLOOD FLOW; STEM CELLS; TISSUE THERAPY;

EID: 79958041008     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020673     Document Type: Article

References (52)

1. Selvin E, Erlinger TP, (2004) Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 110: 738-743.
2. Criqui MH, Alberts MJ, Fowkes FG, Hirsch AT, O'Gara PT, et al. (2008) Atherosclerotic Peripheral Vascular Disease Symposium II: screening for atherosclerotic vascular diseases: should nationwide programs be instituted? Circulation 118: 2830-2836.
3. Aronow H, (2008) Peripheral arterial disease in the elderly: recognition and management. Am J Cardiovasc Drugs 8: 353-364.
4. Minar E, (2009) Critical limb ischaemia. Hamostaseologie 29: 102-109.
5. Slovut DP, Sullivan TM, (2008) Critical limb ischemia: medical and surgical management. Vasc Med 13: 281-291.
6. Higashi Y, Kimura M, Hara K, Noma K, Jitsuiki D, et al. (2004) Autologous bone-marrow mononuclear cell implantation improves endothelium-dependent vasodilation in patients with limb ischemia. Circulation 109: 1215-1218.
7. Losordo DW, Dimmeler S, (2004) Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation 109: 2692-2697.
8. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, et al. (2002) Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360: 427-435.
9. Shintani S, Murohara T, Ikeda H, Ueno T, Sasaki K, et al. (2001) Augmentation of postnatal neovascularization with autologous bone marrow transplantation. Circulation 103: 897-903.
10. Yamamoto K, Kondo T, Suzuki S, Izawa H, Kobayashi M, et al. (2004) Molecular evaluation of endothelial progenitor cells in patients with ischemic limbs: therapeutic effect by stem cell transplantation. Arterioscler Thromb Vasc Biol 24: e192-196.
11. Yoon CH, Hur J, Park KW, Kim JH, Lee CS, et al. (2005) Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 112: 1618-1627.
12. Kudo FA, Nishibe T, Nishibe M, Yasuda K, (2003) Autologous transplantation of peripheral blood endothelial progenitor cells (CD34+) for therapeutic angiogenesis in patients with critical limb ischemia. Int Angiol 22: 344-348.
13. Kamata Y, Takahashi Y, Iwamoto M, Matsui K, Murakami Y, et al. (2007) Local implantation of autologous mononuclear cells from bone marrow and peripheral blood for treatment of ischaemic digits in patients with connective tissue diseases. Rheumatology (Oxford) 46: 882-884.
14. Kolvenbach R, Kreissig C, Ludwig E, Cagiannos C, (2007) Stem cell use in critical limb ischemia. J Cardiovasc Surg (Torino) 48: 39-44.
15. Kajiguchi M, Kondo T, Izawa H, Kobayashi M, Yamamoto K, et al. (2007) Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia. Circ J 71: 196-201.
16. Aranguren XL, Verfaillie CM, Luttun A, (2009) Emerging hurdles in stem cell therapy for peripheral vascular disease. J Mol Med 87: 3-16.
17. Rehman J, Li J, Orschell CM, March KL, (2003) Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107: 1164-1169.
18. Gnecchi M, Zhang Z, Ni A, Dzau VJ, (2008) Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 103: 1204-1219.
19. Kumar AH, Caplice NM, (2010) Clinical potential of adult vascular progenitor cells. Arterioscler Thromb Vasc Biol 30: 1080-1087.
20. Saigawa T, Kato K, Ozawa T, Toba K, Makiyama Y, et al. (2004) Clinical application of bone marrow implantation in patients with arteriosclerosis obliterans, and the association between efficacy and the number of implanted bone marrow cells. Circ J 68: 1189-1193.
21. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, et al. (1999) Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85: 221-228.
22. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, et al. (1999) VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18: 3964-3972.
23. Liu Q, Chen Z, Terry T, McNatt JM, Willerson JT, et al. (2009) Intra-arterial transplantation of adult bone marrow cells restores blood flow and regenerates skeletal muscle in ischemic limbs. Vasc Endovascular Surg 43: 433-443.
24. Reddick RL, Zhang SH, Maeda N, (1994) Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb 14: 141-147.
25. Zhang SH, Reddick RL, Piedrahita JA, Maeda N, (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468-471.
26. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, et al. (2003) Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107: 1322-1328.
27. Aranguren XL, Pelacho B, Penuelas I, Abizanda G, Uriz M, et al. (2010) MAPC transplantation confers a more durable benefit than AC133+ cell transplantation. Cell Transplant.
28. Beauchamp JR, Heslop L, Yu DS, Tajbakhsh S, Kelly RG, et al. (2000) Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol 151: 1221-1234.
29. Charrasse S, Comunale F, Gilbert E, Delattre O, Gauthier-Rouviere C, (2004) Variation in cadherins and catenins expression is linked to both proliferation and transformation of Rhabdomyosarcoma. Oncogene 23: 2420-2430.
30. Wang J, Zhao HP, Lin G, Xie CQ, Nie DS, et al. (2005) In vitro hematopoietic differentiation of human embryonic stem cells induced by co-culture with human bone marrow stromal cells and low dose cytokines. Cell Biol Int 29: 654-661.
31. De Falco E, Porcelli D, Torella AR, Straino S, Iachininoto MG, et al. (2004) SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells. Blood 104: 3472-3482.
32. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, et al. (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10: 858-864.
33. Kalwitz G, Andreas K, Endres M, Neumann K, Notter M, et al. (2009) Chemokine Profile of Human Serum from Whole Blood: Migratory Effects of CXCL-10 and CXCL-11 on Human Mesenchymal Stem Cells. Connect Tissue Res.
34. Wouters K, Shiri-Sverdlov R, van Gorp PJ, van Bilsen M, Hofker MH, (2005) Understanding hyperlipidemia and atherosclerosis: lessons from genetically modified apoe and ldlr mice. Clin Chem Lab Med 43: 470-479.
35. Meir KS, Leitersdorf E, (2004) Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress. Arterioscler Thromb Vasc Biol 24: 1006-1014.
36. Breslow JL, (1996) Mouse models of atherosclerosis. Science 272: 685-688.
37. Strong JP, (1992) Atherosclerotic lesions. Natural history, risk factors, and topography. Arch Pathol Lab Med 116: 1268-1275.
38. Kawamoto A, Asahara T, Losordo DW, (2002) Transplantation of endothelial progenitor cells for therapeutic neovascularization. Cardiovasc Radiat Med 3: 221-225.
39. Sekiguchi H, Ii M, Losordo DW, (2009) The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia. J Cell Physiol 219: 235-242.
40. Zhang S, Shpall E, Willerson JT, Yeh ET, (2007) Fusion of human hematopoietic progenitor cells and murine cardiomyocytes is mediated by alpha 4 beta 1 integrin/vascular cell adhesion molecule-1 interaction. Circ Res 100: 693-702.
41. Zhang S, Wang D, Estrov Z, Raj S, Willerson JT, et al. (2004) Both cell fusion and transdifferentiation account for the transformation of human peripheral blood CD34-positive cells into cardiomyocytes in vivo. Circulation 110: 3803-3807.
42. Donalies M, Cramer M, Ringwald M, Starzinski-Powitz A, (1991) Expression of M-cadherin, a member of the cadherin multigene family, correlates with differentiation of skeletal muscle cells. Proc Natl Acad Sci U S A 88: 8024-8028.
43. Zeschnigk M, Kozian D, Kuch C, Schmoll M, Starzinski-Powitz A, (1995) Involvement of M-cadherin in terminal differentiation of skeletal muscle cells. J Cell Sci 108 (Pt 9): 2973-2981.
44. Maier A, Bornemann A, (2004) M-cadherin transcription in satellite cells from normal and denervated muscle. Am J Physiol Cell Physiol 286: C708-712.
45. Corti S, Strazzer S, Del Bo R, Salani S, Bossolasco P, et al. (2002) A subpopulation of murine bone marrow cells fully differentiates along the myogenic pathway and participates in muscle repair in the mdx dystrophic mouse. Exp Cell Res 277: 74-85.
46. Kilroy GE, Foster SJ, Wu X, Ruiz J, Sherwood S, et al. (2007) Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. J Cell Physiol 212: 702-709.
47. Musaro A, Giacinti C, Borsellino G, Dobrowolny G, Pelosi L, et al. (2004) Stem cell-mediated muscle regeneration is enhanced by local isoform of insulin-like growth factor 1. Proc Natl Acad Sci U S A 101: 1206-1210.
48. Heszele MF, Price SR, (2004) Insulin-like growth factor I: the yin and yang of muscle atrophy. Endocrinology 145: 4803-4805.
49. Borselli C, Storrie H, Benesch-Lee F, Shvartsman D, Cezar C, et al. (2010) Functional muscle regeneration with combined delivery of angiogenesis and myogenesis factors. Proc Natl Acad Sci U S A 107: 3287-3292.
50. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, et al. (1995) Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci U S A 92: 3566-3570.
51. Makinen T, Jussila L, Veikkola T, Karpanen T, Kettunen MI, et al. (2001) Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3. Nat Med 7: 199-205.
52. He Y, Karpanen T, Alitalo K, (2004) Role of lymphangiogenic factors in tumor metastasis. Biochim Biophys Acta 1654: 3-12.